Author/Authors :
Mario Talajic، نويسنده , , Mario and Khairy، نويسنده , , Paul C. Levesque، نويسنده , , Sylvie and Connolly، نويسنده , , Stuart J. and Dorian، نويسنده , , Paul and Dubuc، نويسنده , , Marc and Guerra، نويسنده , , Peter G. and Hohnloser، نويسنده , , Stefan H. and Lee، نويسنده , , Kerry L. and Macle، نويسنده , , Laurent and Nattel، نويسنده , , Stanley and Pedersen، نويسنده , , Ole D. and Stevenson، نويسنده , , Lynne Warner and Thibault، نويسنده , , Bernard and Waldo، نويسنده , , Albert L. and Wyse، نويسنده , , D. George and Roy، نويسنده , , Denis، نويسنده ,
Abstract :
Objectives
al of this study was to evaluate the relationship between the presence of sinus rhythm and outcomes in patients with a history of congestive heart failure (CHF) and atrial fibrillation (AF).
ound
lue of sinus rhythm maintenance in patients with AF and heart failure (HF) is uncertain.
s
l of 1,376 patients with AF, ejection fraction ≤35%, and heart failure symptoms were randomized to a rhythm- or rate-control strategy. Detailed efficacy analyses were used to evaluate the independent effects of treatment strategy and the presence of sinus rhythm on cardiovascular outcomes.
s
l, 445 (32%) patients died and 402 (29%) experienced worsening HF. The rhythm-control strategy was not predictive of cardiovascular mortality (hazard ratio [HR]: 0.90, 95% confidence interval [CI]: 0.70 to 1.16; p = 0.41), all-cause death (HR: 0.86, 95% CI: 0.69 to 1.08; p = 0.19), or worsening HF (HR: 0.86, 95% CI: 0.68 to 1.10; p = 0.23). In analyses devised to isolate the effect of underlying rhythm, sinus rhythm was not associated with cardiovascular mortality [HR: 1.22, 95% CI: 0.80 to 1.87; p = 0.35), total mortality [HR: 1.11, 95% CI: 0.78 to 1.58; p = 0.57), or worsening HF [HR: 0.62, 95% CI: 0.37 to 1.02; p = 0.059).
sions
hm-control strategy or the presence of sinus rhythm are not associated with better outcomes in patients with AF and CHF.
Keywords :
Antiarrhythmia agents , ANTICOAGULANTS , atrial fibrillation , Congestive heart failure